ROLE OF CD44 AND CD7 MOLECULES IN MEDIATION OF INFLAMMATORY SYNOVITIS
ROLE OF CD44 AND CD7 MOLECULES IN MEDIATION OF INFLAMMATORY SYNOVITIS
批准号:
6201512
负责人:
Barton F. Haynes
金额:
$21.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2000-08-31
关键词:
CD antigens CD44 molecule T cell receptor T lymphocyte cell cell interaction cytokine genetically modified animals human T cell lymphotropic virus type 1 human tissue hyaluronate hypertrophic osteoarthropathy immunopathology interferon gamma laboratory mouse monocyte protein isoforms rheumatoid arthritis synovitis tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Monocyte-T cell interactions are key events in mediation of pathologic
immune responses. The broad objectives of this project are to study
roles that T cells and monocytes play in rheumatoid arthritis (RA), by
focusing on the roles that CD44 isoforms and CD7 deficient T cells play
in the pathogenesis of RA and in animal models of inflammatory
synovitis. These objectives will be accomplished by the use of
peripheral blood (PB), synovial fluid (SF) and synovial tissue from
patients with RA, as well as evaluation of a series of novel CD44 and
CD7 deficient mouse strains for their ability to develop synovitis when
injected with challenge antigens or when bred to mice susceptible to
HTLV-l tax transgenic mouse arthritis. Specific aims for Project l are
as follows: l) We will study the roles of cytokines in vivo and in vitro
in regulation of hyaluronan (HA) binding to CD44 isoforms on monocytes
and other synovial cell types in RA, and in tax transgenic mice and mice
with collagen-induced arthritis. Study of the cytokines that regulate HA
binding (and therefore HA-induced proinflammatory events) in RA and in
animal models of RA-like synovitis are critical to development of novel
interventional strategies for treatment of RA. 2) We will define the
roles of CD44 isoforms in inflammatory synovitis using: a) total CD44
deficient mice. b) mice selectively deficient only in variant CDT forms
(but expressing the standard CD44 form. CD44S), and c) mice only
expressing select variant CD44 isoforms. CD44 deficient mice will be
studied for their response to antigen-induced arthritis (AIA). and bred
on a HTLV-l tax transgenic background to determine the effect of CD44
selective and total deficiencies on arthritis in HTLV- l tax transgenic
mice. 3) We will study the roles of CD7 deficient T cells and an altered
TCR repertoire in mediation of inflammatory synovitis by isolating CD4+,
CD7-, CD28- T cells from RA and OA PBMC. SF and synovial tissue and
determining the ability of these T cells to produce IFN-gamma and other
cytokines/chemokines in response to T cell activation signals, and by
studying CD7 deficient mice, in the presence and absence of abnormal T
cell receptor (TCR) repertoires in TCR transgenic mice, for their
ability to develop arthritis. Taken together these studies will provide
insight into the roles that T cells and monocytes play in inflammatory
synovitis. and provide new targets for novel therapeutic interventions
in RA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Administrative Core
-
批准号:10842499
-
项目类别:
-
资助金额:$40.84万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Core 1: Administrative Core
-
批准号:10327520
-
项目类别:
-
资助金额:$67.6万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Project 1: Panbetacoronavirus vaccines
-
批准号:10842502
-
项目类别:
-
资助金额:$109.21万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
-
批准号:10842504
-
项目类别:
-
资助金额:$93.61万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
-
批准号:10327525
-
项目类别:
-
资助金额:$190.5万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Design and Development of a Pan-betacoronavirus Vaccine
-
批准号:10842498
-
项目类别:
-
资助金额:$1047.8万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Core 3: Non-human Primate Core
-
批准号:10327522
-
项目类别:
-
资助金额:$448.74万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Project 1: Panbetacoronavirus vaccines
-
批准号:10327523
-
项目类别:
-
资助金额:$190.5万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Core 3: Non-human Primate Core
-
批准号:10842501
-
项目类别:
-
资助金额:$279.88万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Design and Development of a Pan-betacoronavirus Vaccine
-
批准号:10327519
-
项目类别:
-
资助金额:$1752.2万
-
财政年份:2021
-
负责人:Barton F. Haynes
-
依托单位:
Core-001
-
批准号:10544855
-
项目类别:
-
资助金额:$120.82万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies
-
批准号:10355426
-
项目类别:
-
资助金额:$387.82万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
-
批准号:10355428
-
项目类别:
-
资助金额:$219.75万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Induction of protective antibodies for HIV vaccine development
-
批准号:10450150
-
项目类别:
-
资助金额:$2789.23万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Administrative Core
-
批准号:10355427
-
项目类别:
-
资助金额:$49.54万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Induction of protective antibodies for HIV vaccine development
-
批准号:9977914
-
项目类别:
-
资助金额:$2634.79万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Induction of protective antibodies for HIV vaccine development
-
批准号:10656276
-
项目类别:
-
资助金额:$3040.14万
-
财政年份:2019
-
负责人:Barton F. Haynes
-
依托单位:
Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages
-
批准号:10338057
-
项目类别:
-
资助金额:$618.31万
-
财政年份:2018
-
负责人:Barton F. Haynes
-
依托单位:
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
-
批准号:10338059
-
项目类别:
-
资助金额:$209.95万
-
财政年份:2018
-
负责人:Barton F. Haynes
-
依托单位:
Administrative Core
-
批准号:10097986
-
项目类别:
-
资助金额:$362.24万
-
财政年份:2018
-
负责人:Barton F. Haynes
-
依托单位:
海外基金